81 FR 66028 - Agency Forms Undergoing Paperwork Reduction Act Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 81, Issue 186 (September 26, 2016)
Centers for Disease Control and Prevention
Federal Register Volume 81, Issue 186 (September 26, 2016)
| Page Range | 66028-66029 | |
| FR Document | 2016-23073 |
[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)] [Notices] [Pages 66028-66029] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-23073] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-16-1011] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to [email protected]. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written comments should be received within 30 days of this notice. Proposed Project Emergency Epidemic Investigation Data Collections (OMB Control Number 0920-1011, Expiration 03-31-2017)--Extension -- Division of Scientific Education and Professional Development, Center for Surveillance, Education, and Laboratory Services, Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC previously conducted Emergency Epidemic Investigations (EEIs) under OMB Control Number 0920-0008. In 2013, CDC received OMB approval (OMB Control Number 0920-1011) for a new OMB generic clearance for a three-year period to collect vital information during EEIs in response to urgent outbreaks or events (i.e., natural, biological, chemical, nuclear, radiological) characterized by undetermined agents, undetermined sources, undetermined transmission, or undetermined risk factors. CDC seeks OMB approval for an extension of this generic clearance (OMB control number 0920-1011) for a three-year period. Supporting effective emergency epidemic investigations is one of the most important ways that CDC protects the health of the public. CDC is frequently called upon to conduct EEIs at the request of local, state, or international health authorities seeking support to respond to urgent outbreaks or urgent public health-related events. In response to external partner requests, CDC provides necessary epidemiologic support to identify the agents, sources, modes of transmission, or risk factors to effectively implement rapid prevention and control measures to protect the public's health. Data collection is a critical component of the epidemiologic support provided by CDC; data are analyzed to determine the agents, sources, modes of transmission, or risk factors so that effective prevention and control measures can be implemented. During an unanticipated outbreak or event, immediate action by CDC is necessary to minimize or prevent public harm. The legal justification for EEIs are found in the Public Health Service Act (42 U.S.C. Sec. 301[241](a). Successful investigations are dependent on rapid and flexible data collection that evolves during the investigation and is customized to the unique circumstances of each outbreak or event. Data collection elements will be those necessary to identify the agents, sources, mode of transmission, or risk factors. Examples of potential data collection methods include telephone or face-to-face interview; email, web or other type of electronic questionnaire; paper-and-pencil questionnaire; focus groups; medical record review; laboratory record review; collection of clinical samples; and environmental assessment. Respondents will vary depending on the nature of the outbreak or event; examples of potential respondents include health care professionals, patients, laboratorians, and the general public. Participation in EEIs is voluntary and there are no anticipated costs to respondents other than their time. CDC will use the information gathered during EEIs to rapidly identify and effectively implement measures to minimize or prevent public harm. CDC projects 60 EEIs in response to outbreaks or events characterized by undetermined agents, undetermined sources, undetermined transmission, or undetermined risk factors annually. The projected average number of respondents is 200 per EEI, for a total of 12,000 respondents. CDC estimates the average burden per response is 0.5 hours and each respondent will be asked to respond once. Therefore, the total estimated annual burden hours are 6,000. These estimates are based on the reported burden for EEIs that have been performed during the previous two years. OMB approval is requested for three years. Participation is based on previous Emergency Epidemic Investigations. There are no costs to respondents. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Average Number of Number of burden per Type of respondents Form name respondents responses per response (in respondent hrs.) ---------------------------------------------------------------------------------------------------------------- Emergency Epidemic Investigation Emergency Epidemic 12,000 1 30/60 Participants. Investigation Data Collection Instruments. ---------------------------------------------------------------------------------------------------------------- [[Page 66029]] Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016-23073 Filed 9-23-16; 8:45 am] BILLING CODE 4163-18-P
![66028 Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices
Leroy A. Richardson, instruments, call (404) 639–7570 or sources, modes of transmission, or risk
Chief, Information Collection Review Office, send an email to omb@cdc.gov. Written factors so that effective prevention and
Office of Scientific Integrity, Office of the comments and/or suggestions regarding control measures can be implemented.
Associate Director for Science, Office of the the items contained in this notice During an unanticipated outbreak or
Director, Centers for Disease Control and should be directed to the Attention: event, immediate action by CDC is
Prevention.
CDC Desk Officer, Office of Management necessary to minimize or prevent public
[FR Doc. 2016–23074 Filed 9–23–16; 8:45 am]
and Budget, Washington, DC 20503 or harm. The legal justification for EEIs are
BILLING CODE 4163–18–P by fax to (202) 395–5806. Written found in the Public Health Service Act
comments should be received within 30 (42 U.S.C. Sec. 301[241](a).
days of this notice. Successful investigations are
DEPARTMENT OF HEALTH AND
HUMAN SERVICES Proposed Project dependent on rapid and flexible data
collection that evolves during the
Centers for Disease Control and Emergency Epidemic Investigation investigation and is customized to the
Prevention Data Collections (OMB Control Number unique circumstances of each outbreak
0920–1011, Expiration 03–31–2017)— or event. Data collection elements will
[30Day–16–1011] Extension — Division of Scientific be those necessary to identify the
Education and Professional agents, sources, mode of transmission,
Agency Forms Undergoing Paperwork Development, Center for Surveillance,
Reduction Act Review or risk factors. Examples of potential
Education, and Laboratory Services, data collection methods include
The Centers for Disease Control and Centers for Disease Control and telephone or face-to-face interview;
Prevention (CDC) has submitted the Prevention (CDC). email, web or other type of electronic
following information collection request Background and Brief Description questionnaire; paper-and-pencil
to the Office of Management and Budget questionnaire; focus groups; medical
(OMB) for review and approval in CDC previously conducted Emergency
record review; laboratory record review;
accordance with the Paperwork Epidemic Investigations (EEIs) under
collection of clinical samples; and
Reduction Act of 1995. The notice for OMB Control Number 0920–0008. In
environmental assessment. Respondents
the proposed information collection is 2013, CDC received OMB approval
will vary depending on the nature of the
published to obtain comments from the (OMB Control Number 0920–1011) for a
outbreak or event; examples of potential
public and affected agencies. new OMB generic clearance for a three-
respondents include health care
Written comments and suggestions year period to collect vital information
professionals, patients, laboratorians,
from the public and affected agencies during EEIs in response to urgent
and the general public. Participation in
concerning the proposed collection of outbreaks or events (i.e., natural,
EEIs is voluntary and there are no
information are encouraged. Your biological, chemical, nuclear,
anticipated costs to respondents other
comments should address any of the radiological) characterized by
than their time. CDC will use the
following: (a) Evaluate whether the undetermined agents, undetermined
information gathered during EEIs to
proposed collection of information is sources, undetermined transmission, or
rapidly identify and effectively
necessary for the proper performance of undetermined risk factors. CDC seeks
implement measures to minimize or
the functions of the agency, including OMB approval for an extension of this
prevent public harm.
whether the information will have generic clearance (OMB control number
practical utility; (b) Evaluate the 0920–1011) for a three-year period. CDC projects 60 EEIs in response to
accuracy of the agencies estimate of the Supporting effective emergency outbreaks or events characterized by
burden of the proposed collection of epidemic investigations is one of the undetermined agents, undetermined
information, including the validity of most important ways that CDC protects sources, undetermined transmission, or
the methodology and assumptions used; the health of the public. CDC is undetermined risk factors annually. The
(c) Enhance the quality, utility, and frequently called upon to conduct EEIs projected average number of
clarity of the information to be at the request of local, state, or respondents is 200 per EEI, for a total
collected; (d) Minimize the burden of international health authorities seeking of 12,000 respondents. CDC estimates
the collection of information on those support to respond to urgent outbreaks the average burden per response is 0.5
who are to respond, including through or urgent public health-related events. hours and each respondent will be
the use of appropriate automated, In response to external partner requests, asked to respond once. Therefore, the
electronic, mechanical, or other CDC provides necessary epidemiologic total estimated annual burden hours are
technological collection techniques or support to identify the agents, sources, 6,000. These estimates are based on the
other forms of information technology, modes of transmission, or risk factors to reported burden for EEIs that have been
e.g., permitting electronic submission of effectively implement rapid prevention performed during the previous two
responses; and (e) Assess information and control measures to protect the years.
collection costs. public’s health. Data collection is a OMB approval is requested for three
To request additional information on critical component of the epidemiologic years. Participation is based on previous
the proposed project or to obtain a copy support provided by CDC; data are Emergency Epidemic Investigations.
of the information collection plan and analyzed to determine the agents, There are no costs to respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
mstockstill on DSK3G9T082PROD with NOTICES
Average
Number of
Number of burden per
Type of respondents Form name responses per
respondents response
respondent (in hrs.)
Emergency Epidemic Investigation Partici- Emergency Epidemic Investigation Data Col- 12,000 1 30/60
pants. lection Instruments.
VerDate Sep<11>2014 19:40 Sep 23, 2016 Jkt 238001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\26SEN1.SGM 26SEN1](https://thefederalregister.org/doc/81_FR_66214/page/1.svg)
![Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices 66029
Leroy A. Richardson, Control and Prevention, Department of Officer, NIOSH, CDC, 1095 Willowdale
Chief, Information Collection Review Office, Health and Human Services, has been Road, Mailstop G905, Morgantown,
Office of Scientific Integrity, Office of the renewed for a 2-year period through West Virginia 26506, Telephone: (304)
Associate Director for Science, Office of the September 18, 2018. 285–5976.
Director, Centers for Disease Control and For information, contact M. Chris The Director, Management Analysis
Prevention. Langub, Ph.D., Designated Federal and Services Office, has been delegated
[FR Doc. 2016–23073 Filed 9–23–16; 8:45 am] Officer, Disease, Disability, and Injury the authority to sign Federal Register
BILLING CODE 4163–18–P Prevention and Control Special notices pertaining to announcements of
Emphasis Panel, Centers for Disease meetings and other committee
Control and Prevention, Department of management activities, for both the
DEPARTMENT OF HEALTH AND Health and Human Services, 1600 Centers for Disease Control and
HUMAN SERVICES (HHS) Clifton Road NE., Mailstop K48, Atlanta, Prevention and the Agency for Toxic
Centers for Disease Control and Georgia 30329, telephone (770) 488– Substances and Disease Registry.
Prevention (CDC) 3585 or fax (770) 488–4887.
Elaine L. Baker,
The Director, Management Analysis
and Services Office, has been delegated Director, Management Analysis and Services
Breast and Cervical Cancer Early Office, Centers for Disease Control and
Detection and Control Advisory the authority to sign Federal Register
Prevention.
Committee (BCCEDCAC): Notice of notices pertaining to announcements of
[FR Doc. 2016–23056 Filed 9–23–16; 8:45 am]
Charter Renewal meetings and other committee
BILLING CODE 4163–18–P
management activities, for both the
This gives notice under the Federal Centers for Disease Control and
Advisory Committee Act (Pub. L. 92– Prevention and the Agency for Toxic
463) of October 6, 1972, that the charter DEPARTMENT OF HEALTH AND
Substances and Disease Registry.
for the Breast and Cervical Cancer Early HUMAN SERVICES
Detection and Control Advisory Elaine L. Baker,
Director, Management Analysis and Services Centers for Disease Control and
Committee, Department of Health and
Office, Centers for Disease Control and Prevention
Human Services, has been renewed for
a 2-year period through September 12, Prevention.
[FR Doc. 2016–23054 Filed 9–23–16; 8:45 am]
Advisory Committee on Immunization
2018. Practices
For information, contact Ms. Jameka BILLING CODE 4163–18–P
Blackmon, Designated Federal Officer, In accordance with section 10(a)(2) of
BCCEDCAC, CDC, 1600 Clifton Road the Federal Advisory Committee Act
NE., M/S K57, Atlanta, Georgia, 30329, DEPARTMENT OF HEALTH AND (Pub. L. 92–463), the Centers for Disease
telephone (770) 488–4740; fax (770) HUMAN SERVICES Control and Prevention (CDC)
488–3230. announces the following meeting of the
The Director, Management Analysis Centers for Disease Control and aforementioned committee.
and Services Office, has been delegated Prevention Time and Date:
the authority to sign Federal Register 8:00 a.m.–6:00 p.m., EDT, October 19,
Disease, Disability, and Injury
notices pertaining to announcements of 2016
Prevention and Control Special 8:00 a.m.–3:30 p.m., EDT, October 20,
meetings and other committee Emphasis Panel (SEP): Initial Review
management activities, for both the 2016
Centers for Disease Control and In accordance with Section 10(a)(2) of Place: CDC, Tom Harkin Global
Prevention and the Agency for Toxic the Federal Advisory Committee Act Communications Center, 1600 Clifton
Substances and Disease Registry. (Pub. L. 92–463), the Centers for Disease Road NE., Building 19, Kent ‘‘Oz’’
Control and Prevention (CDC) Nelson Auditorium, Atlanta, Georgia
Elaine L. Baker, 30329.
announces a meeting for the initial
Director, Management Analysis and Services review of applications in response to Status: Open to the public, limited
Office, Centers for Disease Control and only by the space available. Time will
Prevention.
PAR 13–129, Occupational Safety and
Health Research, NIOSH Member be available for public comment. The
[FR Doc. 2016–23057 Filed 9–23–16; 8:45 am] public is welcome to submit written
Conflict Review.
BILLING CODE 4163–18–P
Time and Date: 1:00 p.m.–5:00 p.m., comments in advance of the meeting.
EDT, October 20, 2016 (Closed). Comments should be submitted in
Place: Teleconference. writing by email to the contact person
DEPARTMENT OF HEALTH AND Status: The meeting will be closed to listed below. The deadline for receipt is
HUMAN SERVICES the public in accordance with October 11, 2016. All written comments
provisions set forth in Section must contain the name, address, and
Centers for Disease Control and
552b(c)(4) and (6), Title 5 U.S.C., and organizational affiliation of the speaker,
Prevention
the Determination of the Director, as well as the topic being addressed.
Disease, Disability, and Injury Management Analysis and Services Written comments should not exceed
Prevention and Control Special Office, CDC, pursuant to Public Law 92– one single-spaced typed page in length
Emphasis Panel: Notice of Charter 463. and delivered in 3 minutes or less.
Matters for Discussion: The meeting Please note that the public comment
mstockstill on DSK3G9T082PROD with NOTICES
Renewal
will include the initial review, period may end before the time
This gives notice under the Federal discussion, and evaluation of indicated, following the last call for
Advisory Committee Act (Pub. L. 92– applications received in response to comments. Members of the public who
463) of October 6, 1972, that the charter ‘‘PAR 13–129, NIOSH Member Conflict wish to provide public comments
for the Disease, Disability, and Injury Review.’’ should plan to attend the public
Prevention and Control Special Contact Person for More Information: comment session at the start time listed.
Emphasis Panel, Centers for Disease Nina Turner, Ph.D., Scientific Review Written comments received in advance
VerDate Sep<11>2014 19:40 Sep 23, 2016 Jkt 238001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\26SEN1.SGM 26SEN1](https://thefederalregister.org/doc/81_FR_66214/page/2.svg)
Document Created: 2018-02-09 13:23:20
Document Modified: 2018-02-09 13:23:20
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 81 FR 66028 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR